REPORT ID 137303

Global Secondary Progressive Multiple Sclerosis Drug Market Study 2016-2026, by Segment (Inebilizumab

Publish Date
Nov-19
Pages
66
Format
Electronic (PDF)

ummary

The global Secondary Progressive Multiple Sclerosis Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. 
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Inebilizumab?
        GLX-1112?
        DC-TAB?
        Etomoxir?
        IB-MS?
        Others
Demand Coverage (Market Size & Forecast,  Consumer Distribution):
        Hospital?
        Clinic?
        Others
Company Coverage (Sales data, Main Products & Services etc.):
        AB Science SA?
        Actelion Ltd?
        Biogen, Inc.?
        F. Hoffmann-La Roche Ltd.?
        Genzyme Corporation?
        Glialogix, Inc.?
        Immune Response BioPharma, Inc.?
        Innate Immunotherapeutics Ltd?
        Kyorin Pharmaceutical Co., Ltd.?
        Mallinckrodt Plc?
        MedDay SA?
        MedImmune, LLC?
        Merck KGaA?
        Meta-IQ ApS?
        Novartis AG?
        Opexa Therapeutics, Inc.?
        Xenetic Biosciences (UK) Limited
Major Region Market
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa 
			   
Table of Content
1 Industry Overview
    1.1 Secondary Progressive Multiple Sclerosis Drug Industry
        1.1.1 Overview
        1.1.2 Products of Major Companies
    1.2 Market Segment
        1.2.1 Industry Chain
        1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
2 Secondary Progressive Multiple Sclerosis Drug Market by Type
    2.1 By Type
       2.1.1 Inebilizumab?
       2.1.2 GLX-1112?
       2.1.3 DC-TAB?
       2.1.4 Etomoxir?
       2.1.5 IB-MS?
       2.1.6 Others
    2.2 Market Size by Type
    2.3 Market Forecast by Type
3 Global Market Demand
    3.1 Segment Overview
        3.1.1 Hospital?
        3.1.2 Clinic?
        3.1.3 Others
    3.2 Market Size by Demand
    3.3 Market Forecast by Demand
4 Major Region Market
    4.1 Global Market Overview
        4.1.1 Market Size & Growth
        4.1.2 Market Forecast
    4.2 Major Region
        4.2.1 Market Size & Growth
        4.2.2 Market Forecast
5 Major Companies List
    5.1 AB Science SA? (Company Profile, Sales Data etc.)
    5.2 Actelion Ltd? (Company Profile, Sales Data etc.)
    5.3 Biogen, Inc.? (Company Profile, Sales Data etc.)
    5.4 F. Hoffmann-La Roche Ltd.? (Company Profile, Sales Data etc.)
    5.5 Genzyme Corporation? (Company Profile, Sales Data etc.)
    5.6 Glialogix, Inc.? (Company Profile, Sales Data etc.)
    5.7 Immune Response BioPharma, Inc.? (Company Profile, Sales Data etc.)
    5.8 Innate Immunotherapeutics Ltd? (Company Profile, Sales Data etc.)
    5.9 Kyorin Pharmaceutical Co., Ltd.? (Company Profile, Sales Data etc.)
    5.10 Mallinckrodt Plc? (Company Profile, Sales Data etc.)
    5.11 MedDay SA? (Company Profile, Sales Data etc.)
    5.12 MedImmune, LLC? (Company Profile, Sales Data etc.)
    5.13 Merck KGaA? (Company Profile, Sales Data etc.)
    5.14 Meta-IQ ApS? (Company Profile, Sales Data etc.)
    5.15 Novartis AG? (Company Profile, Sales Data etc.)
    5.16 Opexa Therapeutics, Inc.? (Company Profile, Sales Data etc.)
    5.17 Xenetic Biosciences (UK) Limited (Company Profile, Sales Data etc.)
6 Conclusion